Article
Biomarkers for the detection of circulating tumor cells
12 Apr 2025
Abstract excerpt
Circulating tumor cells (CTCs) have emerged as a key biomarker in cancer detection and prognosis, and their molecular profiling is gaining importance in precision oncology. Liquid biopsies, which allow the extraction of CTCs, circulating tumor DNA (ctDNA) or cell-free DNA (cfDNA), have measurable advantages over traditional tissue biopsies, especially when molecular material is difficult to obtain. However, this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
